Stay updated on APX005M + Pembrolizumab in Metastatic Melanoma Clinical Trial

Sign up to get notified when there's something new on the APX005M + Pembrolizumab in Metastatic Melanoma Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the APX005M + Pembrolizumab in Metastatic Melanoma Clinical Trial page

  1. Check
    yesterday
    Change Detected
    Summary
    A new history version (version 39) was added for NCT02706353 on 2025-10-08, indicating ongoing Quality Control Review and a results return date of 2025-10-23.
    Difference
    2%
    Check dated 2025-10-27T20:56:11.000Z thumbnail image
  2. Check
    8 days ago
    No Change Detected
  3. Check
    15 days ago
    No Change Detected
  4. Check
    23 days ago
    Change Detected
    Summary
    - Added a government-operating-status notice and a link to official sources, indicating the page may have dynamic status information. - Updated version from v3.1.0 to v3.2.0, signaling a new release.
    Difference
    9%
    Check dated 2025-10-06T07:58:00.000Z thumbnail image
  5. Check
    30 days ago
    Change Detected
    Summary
    Version update: from v3.0.2 to v3.1.0. This is a metadata revision with no substantive content changes.
    Difference
    0.2%
    Check dated 2025-09-29T04:28:57.000Z thumbnail image
  6. Check
    44 days ago
    Change Detected
    Summary
    Page revision updated from v3.0.1 to v3.0.2; the Back to Top element was removed with no substantive content changes detected.
    Difference
    0.6%
    Check dated 2025-09-14T21:54:36.000Z thumbnail image
  7. Check
    51 days ago
    Change Detected
    Summary
    The web page has been updated from version 3.0.0 to version 3.0.1, indicating a revision in the content. There are no significant changes in core content or other important factors.
    Difference
    0.6%
    Check dated 2025-09-07T18:57:04.000Z thumbnail image
  8. Check
    58 days ago
    Change Detected
    Summary
    The web page has undergone significant updates, including the addition of a facility name and location details, while removing specific state, country, and city information. This suggests a shift towards a more generalized presentation of location data.
    Difference
    47%
    Check dated 2025-08-31T12:21:50.000Z thumbnail image

Stay in the know with updates to APX005M + Pembrolizumab in Metastatic Melanoma Clinical Trial

Enter your email address, and we'll notify you when there's something new on the APX005M + Pembrolizumab in Metastatic Melanoma Clinical Trial page.